These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18758760)

  • 1. Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice.
    Nakamura A; Narita M; Miyoshi K; Shindo K; Okutsu D; Suzuki M; Higashiyama K; Suzuki T
    Psychopharmacology (Berl); 2008 Oct; 200(3):307-16. PubMed ID: 18758760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
    Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
    Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.
    Narita M; Nakamura A; Ozaki M; Imai S; Miyoshi K; Suzuki M; Suzuki T
    Neuropsychopharmacology; 2008 Apr; 33(5):1097-112. PubMed ID: 17593930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.
    Ozaki S; Narita M; Narita M; Ozaki M; Khotib J; Suzuki T
    J Neurochem; 2004 Mar; 88(6):1389-97. PubMed ID: 15009639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
    Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
    Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
    Ozaki S; Narita M; Narita M; Iino M; Sugita J; Matsumura Y; Suzuki T
    J Neurochem; 2002 Sep; 82(5):1192-8. PubMed ID: 12358766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state.
    Niikura K; Narita M; Narita M; Nakamura A; Okutsu D; Ozeki A; Kurahashi K; Kobayashi Y; Suzuki M; Suzuki T
    Neurosci Lett; 2008 Apr; 435(3):257-62. PubMed ID: 18359165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state.
    Narita M; Imai S; Nakamura A; Ozeki A; Asato M; Rahmadi M; Sudo Y; Hojo M; Uezono Y; Devi LA; Kuzumaki N; Suzuki T
    Addict Biol; 2013 Jul; 18(4):614-22. PubMed ID: 21812868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of spinal protein kinase C in the suppression of morphine-induced rewarding effect under a neuropathic pain-like state in mice.
    Narita M; Oe K; Kato H; Shibasaki M; Narita M; Yajima Y; Yamazaki M; Suzuki T
    Neuroscience; 2004; 125(3):545-51. PubMed ID: 15099668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice.
    Nozaki C; Kamei J
    Eur J Pharmacol; 2006 Dec; 552(1-3):99-104. PubMed ID: 17056034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mesolimbic dopaminergic network in neuropathic pain relief by treadmill exercise: A study for specific neural control with Gi-DREADD in mice.
    Wakaizumi K; Kondo T; Hamada Y; Narita M; Kawabe R; Narita H; Watanabe M; Kato S; Senba E; Kobayashi K; Kuzumaki N; Yamanaka A; Morisaki H; Narita M
    Mol Pain; 2016; 12():. PubMed ID: 27909152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer.
    Watanabe M; Narita M; Hamada Y; Yamashita A; Tamura H; Ikegami D; Kondo T; Shinzato T; Shimizu T; Fukuchi Y; Muto A; Okano H; Yamanaka A; Tawfik VL; Kuzumaki N; Navratilova E; Porreca F; Narita M
    Mol Pain; 2018; 14():1744806918756406. PubMed ID: 29357732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.
    Narita M; Nagumo Y; Hashimoto S; Narita M; Khotib J; Miyatake M; Sakurai T; Yanagisawa M; Nakamachi T; Shioda S; Suzuki T
    J Neurosci; 2006 Jan; 26(2):398-405. PubMed ID: 16407535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model.
    Wu Y; Na X; Zang Y; Cui Y; Xin W; Pang R; Zhou L; Wei X; Li Y; Liu X
    Biochem Biophys Res Commun; 2014 Jul; 449(4):502-7. PubMed ID: 24845379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.
    Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B
    J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The projections from the anterior cingulate cortex to the nucleus accumbens and ventral tegmental area contribute to neuropathic pain-evoked aversion in rats.
    Gao SH; Shen LL; Wen HZ; Zhao YD; Chen PH; Ruan HZ
    Neurobiol Dis; 2020 Jul; 140():104862. PubMed ID: 32251841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways.
    Yanarates O; Dogrul A; Yildirim V; Sahin A; Sizlan A; Seyrek M; Akgül O; Kozak O; Kurt E; Aypar U
    Anesthesiology; 2010 Mar; 112(3):696-710. PubMed ID: 20179508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nalbuphine could decrease the rewarding effect induced by tramadol in mice while enhancing its antinociceptive activity.
    Abdel-Ghany R; Nabil M; Abdel-Aal M; Barakat W
    Eur J Pharmacol; 2015 Jul; 758():11-5. PubMed ID: 25843409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the circadian rhythm of mRNA expression for µ-opioid receptors in the periaqueductal gray under a neuropathic pain-like state.
    Takada T; Yamashita A; Date A; Yanase M; Suhara Y; Hamada A; Sakai H; Ikegami D; Iseki M; Inada E; Narita M
    Synapse; 2013 May; 67(5):216-23. PubMed ID: 23280810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
    Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
    J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.